Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Trexima migraine relief consistent within patients

May 16, 2007

Recent patents divulge novel analgesic agents

May 15, 2007

Long-term suppression of chorea seen with tetrabenazine in Huntington's disease

May 15, 2007

PTC-124 active in Duchenne muscular dystrophy due to a nonsense mutation

May 15, 2007

Study of dextromethorphan in involuntary emotional expression disorder advances / News in Context

May 15, 2007

Study reveals potential of alemtuzumab in sporadic inclusion body myositis

May 15, 2007

Nippon Shinyaku resolves joint development agreement for TRK-091

May 15, 2007

HDAC inhibition restores learning and memory in a mouse model of neurodegeneration

May 15, 2007

Approvable letter issued by FDA for Merck & Co.'s CINV therapy

May 14, 2007

FDA requests Silenor carcinogenicity study results as part of NDA filing

May 14, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...